ArticleCureus2026
Synovial Chondromatosis of the Elbow: A Case Report and Discussion of Feared Complications.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synovial chondromatosis (SC) is a rare, benign neoplasm of synovium-lined joints that commonly presents with decreased mobility, pain, and swelling. It is believed to arise from mesenchymal cells that undergo cartilaginous metaplasia, the histological hallmark of the disease. There is a concern for malignant transformation to synovial chondrosarcoma (SCH). We report a case of SC with a subsequent literature review regarding malignant transformation. A 69-year-old male presented with a progressive history of right elbow pain and stiffness. On examination, the patient had significant limitation of range of motion (ROM) and tenderness of the elbow. X-rays and MRI showed findings suggestive of SC. This was treated operatively with removal of the loose bodies, and the patient was able to return to all his activities pain free. The Boolean search strategy of PubMed was utilized to include articles from 1980 to 2025. A total of 611 articles were identified, which were narrowed to 17 after blinded tier one and two screenings by three authors utilizing Rayyan. The extracted data included the mean patient age/number of patients, history, affected joints, procedures performed, SC size, follow-up, recurrence, timeline for malignant progression, and treatment used for SCH. Our review found that although plain radiograph is used most for initial assessment, computed tomography is the optimal modality to determine the characteristics of the intra-articular calcifications, while magnetic resonance was best suited for determining extension into surrounding tissues. Of the surgical interventions used, arthroscopy and synovectomy were most used in first-time occurrences. Those who develop recurrence or malignant transformation seek more aggressive intervention such as hemipelvectomy, laminectomy, or amputation. SC can normally be successfully treated with synovectomy. However, it is necessary to balance minimally invasive treatment and to reduce the risk of recurrence or malignant transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.